Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus

GÜÇLÜ M., KÜÇÜKSARAÇ KIYICI D. S., GÜL Z., ÇAVUN S.

19th European Congress of Endocrinology, Lisbon, Portugal, 20 - 23 May 2017, vol.49, pp.115, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 49
  • City: Lisbon
  • Country: Portugal
  • Page Numbers: pp.115
  • Dokuz Eylül University Affiliated: Yes